70 m savings in BPP

Mayne has saved 70 m in operating expenses on BPP .This should have been brought to shareholders attention in the announcement





The GP of women health is the sum of 2 quarters subtract 10.7 m from 43.2 =32.5 m which was equal to PCP , reduction in revenue represents discounts /refunds or free samples . Bear in mind the period was less than 6 month due to the transition period in between .Total operating Mayne operating expenses including nexstellis for 6 month is $45.6m versus TXMD expenses 37876 in 3 month which means 75.752 m in 6 month . Which means mayne pharma selling TXMD products at savings more than 34 m . This also means that we are selling Nexstellis amongst this products at no cost so mayne pharma saved the 36m Nexstellis operating cost . Can you count ? . So any increase in the sales will return direct profitability